Mark C. Schneyer
EVP, CHIEF FINANCIAL OFFICER
Common Stock
- Reported value
- $169.64K
- Reported price
- $29.0029 / share
ACADIA PHARMACEUTICALS INC
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
EVP, CHIEF FINANCIAL OFFICER
Common Stock
EVP, CHIEF FINANCIAL OFFICER
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
EVP, CHIEF FINANCIAL OFFICER
Common Stock
EVP, Head of Research & Dev
Common Stock
EVP, Head of Research & Dev
Common Stock
PRINCIPAL ACCOUNTING OFFICER
Common Stock
PRINCIPAL ACCOUNTING OFFICER
Common Stock
PRINCIPAL ACCOUNTING OFFICER
Common Stock
EVP, CHIEF FINANCIAL OFFICER
Common Stock
EVP, CHIEF FINANCIAL OFFICER
Common Stock
PRINCIPAL ACCOUNTING OFFICER
Common Stock
Chief Executive Officer
Common Stock
EVP, Head of Research & Dev
Common Stock
EVP, CHIEF LEGAL OFFICER, SEC
Common Stock
PRINCIPAL ACCOUNTING OFFICER
Common Stock
PRINCIPAL ACCOUNTING OFFICER
Common Stock
PRINCIPAL ACCOUNTING OFFICER
Common Stock
EVP, CHIEF FINANCIAL OFFICER
Common Stock
EVP, CHIEF FINANCIAL OFFICER
Common Stock
EVP, CHIEF FINANCIAL OFFICER
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| EVP, CHIEF FINANCIAL OFFICER | Common StockSale10b5-1 | 5,849$29.00 / share | $169.64K | Aug 5Filed Aug 7 · 2d later | SEC filing |
| EVP, CHIEF FINANCIAL OFFICER | Common StockSale10b5-12 trades | 14,292avg $29.22 / share | $417.6K | Aug 6Filed Aug 7 · 1d later | 2 filings
|
| EVP, Head of Research & Dev | Common StockSale10b5-12 trades | 16,558avg $26.13 / share | $432.66K | Jul 30Filed Jul 31 · 1d later | 2 filings
|
| PRINCIPAL ACCOUNTING OFFICER | Common StockSale10b5-1 | 11,421$26.08 / share | $297.91K | Jun 26Filed Jun 29 · 3d later | SEC filing |
| PRINCIPAL ACCOUNTING OFFICER | Common StockSale | 5,401$21.18 / share | $114.39K | May 26Filed May 27 · 1d later | SEC filing |
| PRINCIPAL ACCOUNTING OFFICER | Common StockSale10b5-1 | 1,332$21.79 / share | $29.02K | May 4Filed May 5 · 1d later | SEC filing |
| EVP, CHIEF FINANCIAL OFFICER | Common StockSale10b5-1 | 3,506$21.79 / share | $76.4K | May 4Filed May 5 · 1d later | SEC filing |
| EVP, CHIEF FINANCIAL OFFICER | Common StockSale10b5-1 | 2,709$22.20 / share | $60.14K | Apr 7Filed Apr 7 · 0d later | SEC filing |
| PRINCIPAL ACCOUNTING OFFICER | Common StockSale10b5-1 | 1,030$22.20 / share | $22.87K | Apr 7Filed Apr 7 · 0d later | SEC filing |
| Chief Executive Officer | Common StockSale10b5-1 | 11,641$21.47 / share | $249.93K | Mar 25Filed Mar 26 · 1d later | SEC filing |
| EVP, Head of Research & Dev | Common StockSale10b5-1 | 3,435$21.47 / share | $73.75K | Mar 25Filed Mar 26 · 1d later | SEC filing |
| EVP, CHIEF LEGAL OFFICER, SEC | Common StockSale10b5-1 | 3,844$21.47 / share | $82.53K | Mar 25Filed Mar 26 · 1d later | SEC filing |
| PRINCIPAL ACCOUNTING OFFICER | Common StockSale10b5-1 | 833$21.47 / share | $17.88K | Mar 25Filed Mar 26 · 1d later | SEC filing |
| PRINCIPAL ACCOUNTING OFFICER | Common StockSale10b5-12 trades | 1,109avg $21.65 / share | $24.01K | Mar 26Filed Mar 26 · 0d later | 2 filings
|
| EVP, CHIEF FINANCIAL OFFICER | Common StockSale10b5-1 | 4,177$21.47 / share | $89.68K | Mar 25Filed Mar 26 · 1d later | SEC filing |
| EVP, CHIEF FINANCIAL OFFICER | Common StockSale10b5-12 trades | 3,208avg $21.65 / share | $69.46K | Mar 26Filed Mar 26 · 0d later | 2 filings
|
This reflects the filings imported so far, not a complete trading history.